Dijous 11 de juny, el Dipòsit Digital no estarà operatiu de 15:00 a 17:00 h per tasques de manteniment. Disculpeu les molèsties.
El jueves 11 de Junio, el Dipòsit Digital no estará operativo de 15:00 a 17:00 h debido a tareas de mantenimiento. Disculpen las molestias.
Thursday, Jun 11th, the Digital Repository will be unavailable due to a system update.

Files

714054.pdf (1.9 MB)

Document type

Article

Version

Published version

Publication date

2021-03-17

Publication license

cc-by (c) Carrasco, Raquel et al., 2021
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/183870

Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1038/s41598-021-85137-1

Abstract

This study aimed to ascertain gene expression profle diferences between progressive muscle-invasive bladder cancer (MIBC) and de novo MIBC, and to identify prognostic biomarkers to improve patients' treatment. Retrospective multicenter study in which 212 MIBC patients who underwent radical cystectomy between 2000 and 2019 were included. Gene expression profles were determined in 26 samples using Illumina microarrays. The expression levels of 94 genes were studied by quantitative PCR in an independent set of 186 MIBC patients. In a median follow-up of 16 months, 46.7% patients developed tumor progression after cystectomy. In our series, progressive MIBC patients show a worse tumor progression (p= 0.024) and cancer-specifc survival (CSS) (p= 0.049) than the de novo group. A total of 480 genes were found to be diferently expressed between both groups. Diferential expression of 24 out of the 94 selected genes was found in an independent cohort. RBPMC2 and DSC3 were found as independent prognostic biomarkers of tumor progression and CALD1 and LCOR were identifed as prognostic biomarkers of CSS between both groups. In conclusion, progressive and de novo MIBC patients show diferent clinical outcome and gene expression profles. Gene expression patterns may contribute to predict high-risk of progression to distant metastasis or CSS.

Subject

Expressió gènica, Càncer de bufeta

Subject (English)

Gene expression, Bladder cancer

Citation

Collections

Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)

Citation

CARRASCO, Raquel, et al. Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication. Scientific Reports. 2021. Vol. 11, num. 6132. ISSN 2045-2322. [consulted: 11 of June of 2026]. Available at: https://hdl.handle.net/2445/183870

Export metadata

JSON - METS

Share record